{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:36:29Z","timestamp":1760146589572,"version":"build-2065373602"},"reference-count":37,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"GILEAD","doi-asserted-by":"publisher","award":["210046"],"award-info":[{"award-number":["210046"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>(1) Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease. Although the changes in the expression levels of microRNAs (miRNAs) in hepatitis B virus-related diseases have been evaluated, no study has evaluated the role of miRNAs in HBV vaccine response in MASLD patients. We aimed to determine the miRNA expression profile in MASLD patients according to HBV vaccine response. (2) Methods: Overall, 100 MASLD patients and 100 controls were included, and anti-HBs levels were measured after three doses of HBV vaccine administration. After collecting blood samples, 22 different miRNA expression profiles were analyzed by RT-PCR analysis, and changes in the expression levels of potential miRNAs were further verified in all study groups. (3) Results: The miR-146a expression level considerably increased in MASLD patients compared to the control group. Furthermore, miR-99a and miR-640 expression levels significantly increased in AntiHBs (\u2212) healthy individuals. (4): Conclusions: miR-146a could be used as the diagnostic marker in MASLD patients. Furthermore, the miR-99a and miR-640 expression levels could predict hepatitis B vaccine response. However, validation studies are required to verify the biomarker potential of miRNAs within a more significant number of patients.<\/jats:p>","DOI":"10.3390\/v16111799","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T07:02:58Z","timestamp":1732086178000},"page":"1799","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Predictive Role of miRNAs in Hepatitis B Vaccine Response of Metabolic Dysfunction-Associated Steatotic Liver Disease Patients"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2088-9914","authenticated-orcid":false,"given":"Gamze","family":"Guney Eskiler","sequence":"first","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, Sakarya University, 54290 Sakarya, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1514-1685","authenticated-orcid":false,"given":"Oguz","family":"Karabay","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Sakarya University, 54290 Sakarya, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukaddes","family":"Tozlu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Faculty of Medicine, Sakarya University, 54290 Sakarya, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Aydin","sequence":"additional","affiliation":[{"name":"Department of Internal Sciences, Sakarya University Training and Research Hospital, 54290 Sakarya, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6264-6999","authenticated-orcid":false,"given":"Kaan Furkan","family":"Hamarat","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Sakarya University, 54290 Sakarya, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2530-1526","authenticated-orcid":false,"given":"Umut","family":"Alkurt","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Sakarya University, 54290 Sakarya, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuman","family":"Deveci Ozkan","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, Sakarya University, 54290 Sakarya, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"Gunduz","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, Sakarya University, 54290 Sakarya, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/liv.14369","article-title":"Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?","volume":"40","author":"Zhang","year":"2020","journal-title":"Liver Int."},{"key":"ref_2","unstructured":"(2024, September 19). Global Viral Hepatitis, Available online: https:\/\/www.cdc.gov\/hepatitis\/global\/index.html."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1080\/21645515.2018.1450122","article-title":"Significant transcriptome and cytokine changes in hepatitis B vaccine non-responders revealed by genome-wide comparative analysis","volume":"14","author":"Qiu","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jmv.20524","article-title":"Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines","volume":"78","author":"Zuckerman","year":"2006","journal-title":"J. Med. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"27251","DOI":"10.1038\/srep27251","article-title":"Factors influencing immunologic response to hepatitis B vaccine in adults","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.4254\/wjh.v7.i24.2503","article-title":"Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine","volume":"7","author":"Walayat","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/hep.20716","article-title":"Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness","volume":"41","author":"Godkin","year":"2005","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.clinre.2015.12.011","article-title":"Chronic hepatitis B and fatty liver: Issues in clinical management","volume":"40","author":"Kumar","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.dld.2014.03.014","article-title":"High Prevalence of Hepatitis B Non-Immunity in Pediatric Non Alcoholic Fatty Liver Disease Patients","volume":"46","author":"Mehta","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41541-020-00266-4","article-title":"Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)","volume":"6","author":"Joshi","year":"2021","journal-title":"npj Vaccines"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s43066-021-00084-w","article-title":"The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients","volume":"11","author":"Megahed","year":"2021","journal-title":"Egypt. Liver J."},{"key":"ref_12","first-page":"320","article-title":"Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysis","volume":"19","author":"Wang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"34935","DOI":"10.1038\/srep34935","article-title":"MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C","volume":"6","author":"Appourchaux","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Loureiro, D., Tout, I., Narguet, S., Benazzouz, S.M., Mansouri, A., and Asselah, T. (2020). miRNAs as Potential Biomarkers for Viral Hepatitis B and C. Viruses, 12.","DOI":"10.3390\/v12121440"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.3748\/wjg.v19.i30.4867","article-title":"MicroRNAs may solve the mystery of chronic hepatitis B virus infection","volume":"19","author":"Wei","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107295","DOI":"10.18632\/oncotarget.22364","article-title":"Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: A meta-analysis","volume":"8","author":"Xiong","year":"2017","journal-title":"Oncotarget"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1872-034X.2007.00213.x","article-title":"Hepatitis B virus X protein induces apoptosis and cell cycle deregulation through interfering with DNA repair and checkpoint responses","volume":"38","author":"Chen","year":"2008","journal-title":"Hepatol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"196704","DOI":"10.1155\/2013\/196704","article-title":"Safety and efficacy of hepatitis B vaccination in cirrhosis of liver","volume":"2013","author":"Roni","year":"2013","journal-title":"Adv. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lin, H.Y., Yang, Y.L., Wang, P.W., Wang, F.S., and Huang, Y.H. (2020). The emerging role of microRNAs in NAFLD: Highlight of microRNA-29a in modulating oxidative stress, inflammation, and beyond. Cells, 9.","DOI":"10.3390\/cells9041041"},{"key":"ref_20","first-page":"5188","article-title":"Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B","volume":"18","author":"Zhang","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.24809","article-title":"Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G1-modulated P53 activity","volume":"55","author":"Wang","year":"2012","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1111\/j.1365-2893.2011.01443.x","article-title":"Circulating microRNAs in hepatitis B virus\u2013infected patients","volume":"18","author":"Ji","year":"2011","journal-title":"J. Viral Hepat."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e47490","DOI":"10.1371\/journal.pone.0047490","article-title":"Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycle","volume":"7","author":"Hayes","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2018.08.008","article-title":"miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"69","author":"Liu","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"16163","DOI":"10.1038\/srep16163","article-title":"MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a","volume":"5","author":"Du","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Fr\u00fcndt, T., Krause, L., Hussey, E., Steinbach, B., K\u00f6hler, D., von Felden, J., Schulze, K., Lohse, A.W., Wege, H., and Schwarzenbach, H. (2021). Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients. Cancers, 13.","DOI":"10.3390\/cancers13102484"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1128\/JVI.00619-16","article-title":"Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis","volume":"90","author":"Bandiera","year":"2016","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.4161\/hv.24938","article-title":"Association between microRNA polymorphisms and humoral immunity to hepatitis B vaccine","volume":"9","author":"Xiong","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/CVI.00044-13","article-title":"Increased serum microRNA-155 level associated with nonresponsiveness to hepatitis B vaccine","volume":"20","author":"Xiong","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"36677","DOI":"10.1074\/jbc.M111.270561","article-title":"MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma","volume":"286","author":"Li","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4254\/wjh.v6.i8.613","article-title":"Circulating microRNAs in patients with non-alcoholic fatty liver disease","volume":"6","author":"Celikbilek","year":"2014","journal-title":"World J. Hepatol."},{"key":"ref_33","first-page":"7087","article-title":"Profiles of serum miR-99a, let-7c and miR-125b in hepatitis B virus (HBV)-associated chronic hepatitis, liver cirrhosis and hepatocellular carcinoma","volume":"9","author":"Xiong","year":"2016","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7150\/jca.3.19","article-title":"Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients","volume":"3","author":"Abdalla","year":"2012","journal-title":"J. Cancer"},{"key":"ref_35","first-page":"8988","article-title":"MiR-640 inhibition alleviates acute liver injury via regulating WNT signaling pathway and LRP1","volume":"24","author":"Wang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kitade, H., Chen, G., Ni, Y., and Ota, T. (2017). Nonalcoholic fatty liver disease and insulin resistance: New insights and potential new treatments. Nutrients, 9.","DOI":"10.3390\/nu9040387"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/11\/1799\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:35:53Z","timestamp":1760114153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/11\/1799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["v16111799"],"URL":"https:\/\/doi.org\/10.3390\/v16111799","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2024,11,20]]}}}